Access Statistics for Marisa Miraldo

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are You What You Eat? Experimental Evidence on Health Habits and Risk Preferences 0 0 2 219 0 2 19 451
Are you what you eat? Experimental evidence on risk preferences and health habits 0 0 0 129 0 1 17 151
Bandwagoning, free-riding and heterogeneity in influenza vaccine decisions: an online experiment 0 0 0 9 0 1 15 38
Collusion in regulated pluralistic markets 0 0 0 23 0 0 16 62
Doctor-patient differences in risk preferences, and their links to decision-making: a field experiment 0 0 0 28 0 0 8 97
Doctor–patient differences in risk and time preferences: a field experiment 0 0 1 39 0 0 17 71
Economies of scale and scope in the English hospital sector 1 1 1 113 1 2 6 274
Establishing a Fair Playing Field for Payment by Results 0 0 0 68 0 0 13 240
Hospital Financing and the Development and Adoption of New Technologies 0 0 0 83 0 0 3 293
Identification of Peer Effects using Panel Data 0 0 0 12 1 2 13 39
Identification of Peer Effects using Panel Data 0 0 0 43 0 1 7 54
In sickness but not in wealth: Field evidence on patients’ risk preferences in the financial and health domain 0 0 0 2 0 0 8 84
In sickness but not in wealth: field evidence on patients’ risk preferences in the financial and health domain 0 0 1 58 1 1 18 95
Inequities in cancer drug development in terms of unmet medical need 0 0 0 0 0 0 8 11
Inequities in cancer drug development in terms of unmet medical need 0 0 0 0 0 0 12 18
Inequities in cancer drug development in terms of unmet medical need 0 0 0 0 0 0 9 25
Innovation Diffusion Among Coworkers: Evidence from Senior Doctors 0 0 1 1 2 4 14 14
Innovation Diffusion and Physician Networks: Keyhole Surgery for Cancer in the English NHS 0 0 1 22 0 0 16 56
Innovation Diffusion and Physician Networks: Keyhole Surgery for Cancer in the English NHS 0 0 0 33 1 7 16 72
Optimal Contracts and Contractual Arrangements Within the Hospital: Bargaining vs. Take-it-or-leave-it Offers 0 0 0 71 0 2 7 247
Peer and network effects in medical innovation: the case of laparoscopic surgery in the English NHS 0 0 2 108 1 3 20 203
Physician altruism and moral hazard: (no) evidence from Finnish national prescriptions data 0 0 0 8 0 0 9 43
Post-Diagnosis Trajectories in Treatment, Adiposity, Glycemic Control, and Dietary Behavior Among Adults with Type 2 Diabetes in Mexico 0 0 0 0 0 3 3 3
Price Adjustment in the Hospital Sector 0 0 0 79 0 2 13 303
Price regulation of pluralistic markets subject to provider collusion 0 0 0 24 0 8 14 101
Price regulation of pluralistic markets subject to provider collusion 0 0 0 32 0 1 9 236
Reference Pricing Versus Co-Payment in the Pharmaceutical Industry: Firm's Pricing Strategies 0 0 0 124 0 1 5 422
Reference Pricing Versus Co-Payment in the Pharmaceutical Industry: Price, Quality and Market Coverage 0 0 0 149 0 0 12 339
The costs of new organisational and financial freedom: The case of English NHS trusts 0 0 0 37 1 1 10 185
The determinants of attrition in drug development: a duration analysis 0 0 2 62 0 3 20 186
The incentive effects of payment by results 1 2 3 340 1 2 11 824
Total Working Papers 2 3 14 1,916 9 47 368 5,237


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are English treatment centres treating less complex patients? 0 0 0 19 0 1 8 93
Are You What You Eat? Healthy Behaviour and Risk Preferences 0 0 1 4 0 0 11 31
Bandwagoning, free‐riding and heterogeneity in influenza vaccine decisions: An online experiment 0 0 0 2 1 24 33 41
Broadening the lens: a commentary on Sheard and Cauana-Finkel's account of women's progress in UK academic health economics 0 0 0 0 0 0 4 4
Corrigendum to ‘Broadening the lens: a commentary on Sheard and Cauana-Finkel's account of women's progress in UK academic health economics’ [Soc. Sci. Med. 382, October 2025, 118411] 0 0 0 0 0 1 1 1
Distribution of health-related social surplus in pharmaceuticals: an estimation of consumer and producer surplus in the management of high blood lipids and COPD 0 0 0 7 0 1 11 82
Doctor–patient differences in risk and time preferences: A field experiment 0 0 2 22 0 1 20 123
Does global drug innovation correspond to burden of disease? The neglected diseases in developed and developing countries 0 0 0 15 0 4 14 54
Effects of Reference Pricing in Pharmaceutical Markets 0 0 0 37 1 1 13 184
Erratum to: Distribution of health-related social surplus in pharmaceuticals: an estimation of consumer and producer surplus in the management of high blood lipids and COPD 0 0 0 1 0 1 8 16
Excess influenza hospital admissions and costs due to the 2009 H1N1 pandemic in England 0 0 0 4 1 1 15 52
Food environment and diabetes mellitus in South Asia: A geospatial analysis of health outcome data 0 0 0 0 0 0 7 7
Giving greater financial independence to hospitals—does it make a difference? The case of English NHS Trusts 0 0 0 64 2 2 7 184
Impact of extreme temperatures on emergency hospital admissions by age and socio-economic deprivation in England 0 0 0 2 1 2 12 22
Impacts of introducing and lifting nonpharmaceutical interventions on COVID-19 daily growth rate and compliance in the United States 0 0 0 0 1 5 19 26
In Sickness but Not in Wealth 0 0 0 0 0 1 7 10
Inequities in cancer drug development in terms of unmet medical need 0 0 0 1 0 0 5 11
Innovation Diffusion Among Coworkers: Evidence from Senior Doctors 0 1 10 10 0 2 41 41
Optimal Hospital Care Scheduling During the SARS-CoV-2 Pandemic 0 0 2 4 0 1 10 18
Physician altruism and moral hazard: (no) Evidence from Finnish national prescriptions data 0 0 0 8 0 1 11 71
Price adjustment in the hospital sector 0 0 0 23 0 0 5 134
Projected impact of the Portuguese sugar-sweetened beverage tax on obesity incidence across different age groups: A modelling study 0 0 0 5 0 0 4 36
Reference pricing and firms' pricing strategies 0 0 0 187 0 1 10 761
Should prospective payments be differentiated for public and private healthcare providers? 0 0 0 29 0 0 4 95
The Determinants of Cost-Effectiveness Potential: An Historical Perspective on Lipid-Lowering Therapies 0 0 0 2 2 2 9 39
The effects of hospitals' governance on optimal contracts: Bargaining vs. contracting 0 0 0 33 0 1 7 150
The impact of hospital price and quality transparency tools on healthcare spending: a systematic review 0 0 0 2 0 1 6 18
The impact of publicly subsidised health insurance on access, behavioural risk factors and disease management 0 0 0 3 0 2 11 38
The impact of the consumer and neighbourhood food environment on dietary intake and obesity-related outcomes: A systematic review of causal impact studies 0 0 0 4 0 1 10 36
The importance of surgeons and their peers in adoption and diffusion of innovation: An observational study of laparoscopic colectomy adoption and diffusion in England 0 0 0 4 0 2 14 27
The role of patient organisations in research and development: Evidence from rare diseases 0 0 0 0 0 0 7 9
Waiting time at health facilities and social class: Evidence from the Indian caste system 0 0 0 0 0 0 10 20
Total Journal Articles 0 1 15 492 9 59 354 2,434


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Experimental Methods and Behavioral Insights in Health Economics: Estimating Risk and Time Preferences in Health 0 0 1 6 0 1 7 23
R&D Success in Pharmaceutical Markets: A Duration Model Approach 0 0 0 3 1 2 7 15
Total Chapters 0 0 1 9 1 3 14 38


Statistics updated 2026-10-11